Open original FDA record ↗Recall record
- FDA identifier
- Z-2054-2016
- Company in FDA record
- Nephron Pharmaceuticals Corp.
- FDA classification date
- Jun 27, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Lack of Assurance of Sterility: Internal dye ingress test failure to assure the integrity of the vial.
Source facts
- Action
- Nephron Pharmaceuticals Corporation sent an Urgent Drug Recall letter to all affected customers on November 16, 2015. The letter identified the product, the problem, and the action to be taken by the customer. NPC requested customers remove the affected lots from their inventory, including store shelves. Customers with questions should call 1-844-374-6841
- Initiated
- 2015-11-16
- Root cause
- Process control
- Terminated
- 2017-01-09
- Distribution
- Worldwide Distribution - US including AL, AR, AZ, CA, CO, CT, FL, GA, IL, KY, LA, MA, MI, MN, MO, MS, NC, ND, NE, NH, NJ, NY, OH, OK, OR, PA, PR, SC, TN, TX, UT, VA, VT, WA, WI, WV and Internationally to Canada.
- Recall number
- Z-2054-2016
- Recall status
- Terminated
- CDRH record ID
- 144042
- FDA classified
- 2016-06-27
- Recall event number
- 73395